Neogen® Launches Quantitative Cashew ELISA Assay
September 19, 2022
LANSING, Mich. — Neogen® Corporation (NASDAQ: NEOG) announced today that it has released its innovative Veratox® VIP assay for the detection of cashew, the second assay in Neogen’s new Veratox VIP line of enhanced quantitative ELISA products. The new Veratox VIP for Cashew allergen test demonstrates robust performance across sample types while maintaining the simple testing methodology of [...]
FLUXION LAUNCHES A FULLY PACKAGED ION CHANNEL SCREENING SOLUTION
September 19, 2022
A complete system for lead-to-answer screening in ion channel assays Alameda, CA - Fluxion Biosciences, a global leader in automated patch clamp systems for ion channel drug discovery, today announced the release of an integrated and affordable solution for simplifying automated ion channel assays. Ion channels are the third most significant drug target, after kinases [...]
MGI Launches Ultra High Speed DNBSEQ-G99 Gene Sequencer* with Mid to Low Range Throughput
September 19, 2022
SHENZHEN, China – MGI Tech Co., Ltd. (MGI) on 9 September officially launched DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput. As one of the sequencers* with the fastest speed among those with the same throughput in the world, DNBSEQ-G99* is especially suitable for targeted gene sequencing and small genome sequencing, [...]
Thermo Fisher Scientific introduces customized Dynabeads solutions for scalable mRNA production
September 19, 2022
Image: Overview: The Dynabeads™ Streptavidin for In Vitro Transcription and Dynabeads Carboxylic Acid for RNA Purification solutions support scalable GMP-grade synthesis and purification of mRNA for vaccine development and manufacturing. The fit-for-purpose solutions, combined with Thermo Scientific™ TheraPure™ GMP* [...]
September 19, 2022
Speakers will discuss how genomics drives more informed, inclusive, and proactive care SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will convene a panel titled "Clinical Genomics Is Now. Are You Ready?" at its inaugural Illumina Genomics Forum (IGF), moderated by Nobel laureate and [...]
BIO-TECHNE ISSUES 2022 CORPORATE SUSTAINABILITY REPORT
September 19, 2022
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2022 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initiatives. Bio-Techne's CSR is organized around four key pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. Bio-Techne's EPIC values (Empowerment, Passion, Innovation and Collaboration) remain the backbone [...]
Berkeley Lights Announces Appointment of Scott Chaplin as Chief Legal Officer
September 19, 2022
EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Scott Chaplin has been named the Company's chief legal officer and corporate secretary, effective immediately. Mr. Chaplin will have overall responsibility for the corporate legal function, including contracts, governance, compliance and management of its extensive intellectual property and [...]
September 19, 2022
The new Emulate adeno-associated virus (AAV) transduction application for the Liver-Chip offers the quickest path to AAV optimization and design iteration Boston, MA – Emulate, Inc., a leading provider of next-generation in vitro models, today announced the launch of its new adeno-associated virus (AAV) transduction application for the Liver-Chip that enables gene therapy researchers to test the [...]
Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation
September 19, 2022
BioXp™ 9600 system – a fully automated, high-throughput benchtop instrument for synthetic biology workflows – empowers scientists to accelerate discovery of new vaccines and biologics SAN DIEGO -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release and first shipment of the BioXp™ 9600 system, a next-generation [...]
September 19, 2022
Next-generation platform makes hollow-fiber perfusion technology commercially relevant and delivers advanced software to support cGMP LAKEWOOD, CO, US – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announces the launch of its Quantum Flex Cell Expansion System, a bioreactor platform that supports process development through to commercial manufacturing for the cell and gene [...]

